Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Excitant Therapeutics LLC in September, 2021 for $277,289.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43EY033247-01 | Phase I | 277,289 | September 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Excitant Therapeutics LLC in September, 2022 for $871,180.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44EY032023-02 | Phase II | 871,180 | September 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Excitant Therapeutics LLC in September, 2020 for $271,325.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43EY032023-01 | Phase I | 271,325 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Excitant Therapeutics LLC in September, 2020 for $272,889.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43EY031998-01 | Phase I | 272,889 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Excitant Therapeutics LLC in September, 2019 for $225,239.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43EY029910-01A1 | Phase I | 225,239 | September 1, 2019 |